Literature DB >> 29177911

Mechanisms of Sustained Neutrophilia in Patient WHIM-09, Cured of WHIM Syndrome by Chromothripsis.

Qian Liu1, Zhanzhuo Li1, Alexander Y Yang1, Ji-Liang Gao1, Daniel S Velez1, Elena J Cho1, David H McDermott1, Philip M Murphy2.   

Abstract

WHIM-09 is the first patient described with WHIM syndrome, an autosomal dominant form of neutropenia related to bone marrow retention of neutrophils. Originally diagnosed incorrectly with autoimmune neutropenia, the patient underwent splenectomy at age 9, but the absolute neutrophil count (ANC) did not rise. Subsequently, she was spontaneously cured by chromothripsis (chromosome shattering), which deleted the disease allele CXCR4 R334X , and 163 other genes, on chromosome 2 in a single hematopoietic stem cell (HSC). Chromothriptic CXCR4 +/o HSCs replaced CXCR4 +/R334X WHIM HSCs, and the ANC rose to a new sustained and benign baseline ~ 2-3-fold above normal that had remained unexplained. Here, we show that splenectomized Cxcr4 +/o mice had sustained and benign neutrophilia, phenocopying neutrophilia in WHIM-09. In addition, WHIM-09's granulocyte-macrophage precursor cells possessed increased granulocyte colony-forming activity ex vivo. Thus, WHIM-09's neutrophilia may be multifactorial, involving neutrophil-extrinsic factors (splenectomy), as well as CXCR4 haploinsufficiency-dependent neutrophil-intrinsic factors (increased myeloid precursor cell differentiation). The strong bone marrow retention signal for neutrophils conferred by the WHIM mutation may have prevented neutrophilia after splenectomy until the mutation was deleted by chromothripsis.

Entities:  

Keywords:  CXCR4; HSC; Neutrophilia; WHIM syndrome; chromothripsis; mutation

Mesh:

Substances:

Year:  2017        PMID: 29177911      PMCID: PMC5743603          DOI: 10.1007/s10875-017-0457-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

Review 1.  A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia.

Authors:  M Wetzler; M Talpaz; E S Kleinerman; A King; Y O Huh; J U Gutterman; R Kurzrock
Journal:  Am J Med       Date:  1990-11       Impact factor: 4.965

2.  Chromothriptic cure of WHIM syndrome.

Authors:  David H McDermott; Ji-Liang Gao; Qian Liu; Marie Siwicki; Craig Martens; Paejonette Jacobs; Daniel Velez; Erin Yim; Christine R Bryke; Nancy Hsu; Zunyan Dai; Martha M Marquesen; Elina Stregevsky; Nana Kwatemaa; Narda Theobald; Debra A Long Priel; Stefania Pittaluga; Mark A Raffeld; Katherine R Calvo; Irina Maric; Ronan Desmond; Kevin L Holmes; Douglas B Kuhns; Karl Balabanian; Françoise Bachelerie; Stephen F Porcella; Harry L Malech; Philip M Murphy
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

3.  CXCL12/CXCR4 signaling promotes human thymic dendritic cell survival regulating the Bcl-2/Bax ratio.

Authors:  Carmen Hernández-López; Jaris Valencia; Laura Hidalgo; Víctor G Martínez; Agustín G Zapata; Rosa Sacedón; Alberto Varas; Angeles Vicente
Journal:  Immunol Lett       Date:  2008-08-08       Impact factor: 3.685

4.  Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome.

Authors:  Kevin B Walters; Julie M Green; Jill C Surfus; Sa Kan Yoo; Anna Huttenlocher
Journal:  Blood       Date:  2010-06-30       Impact factor: 22.113

5.  The effect of splenectomy on the leucocyte count.

Authors:  J A McBride; J V Dacie; R Shapley
Journal:  Br J Haematol       Date:  1968-02       Impact factor: 6.998

6.  Beta-Chemokine CCL15 Affects the Adhesion and Migration of Hematopoietic Progenitor Cells.

Authors:  Rudolf Richter; Brigitte Rüster; Roxana Bistrian; Wolf-Georg Forssmann; Erhard Seifried; Reinhard Henschler
Journal:  Transfus Med Hemother       Date:  2014-12-19       Impact factor: 3.747

7.  CXCR4 antagonist AMD3100 redistributes leukocytes from primary immune organs to secondary immune organs, lung, and blood in mice.

Authors:  Qian Liu; Zhanzhuo Li; Ji-Liang Gao; Wuzhou Wan; Sundar Ganesan; David H McDermott; Philip M Murphy
Journal:  Eur J Immunol       Date:  2015-04-24       Impact factor: 5.532

8.  Isolation, purification and labeling of mouse bone marrow neutrophils for functional studies and adoptive transfer experiments.

Authors:  Muthulekha Swamydas; Michail S Lionakis
Journal:  J Vis Exp       Date:  2013-07-10       Impact factor: 1.355

Review 9.  Myelodysplastic syndromes: diagnosis, prognosis, and treatment.

Authors:  Ulrich Germing; Guido Kobbe; Rainer Haas; Norbert Gattermann
Journal:  Dtsch Arztebl Int       Date:  2013-11-15       Impact factor: 5.594

10.  Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3.

Authors:  A F Lopez; L B To; Y C Yang; J R Gamble; M F Shannon; G F Burns; P G Dyson; C A Juttner; S Clark; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

View more
  3 in total

Review 1.  Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.

Authors:  Philip M Murphy; Lauren Heusinkveld
Journal:  Cytokine       Date:  2018-02-15       Impact factor: 3.861

Review 2.  WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure.

Authors:  Lauren E Heusinkveld; Shamik Majumdar; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  J Clin Immunol       Date:  2019-07-16       Impact factor: 8.317

3.  Up-Regulation of Superoxide Dismutase 2 in 3D Spheroid Formation Promotes Therapeutic Potency of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.

Authors:  Miyoung Lee; Bo Ram Song; Dong Hyun Kim; Jueun Ha; Minju Lee; Soo Jin Choi; Wonil Oh; Soyoun Um; Hye Jin Jin
Journal:  Antioxidants (Basel)       Date:  2020-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.